Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Pharma
Biogen's fortunes are trending upward thanks to its new launches
As Leqembi and Skyclarys launches gain steam, Biogen's CEO Chris Viehbacher admitted Wednesday that the company still has “a lot of work to do."
Fraiser Kansteiner
Apr 24, 2024 11:24am
Experts paint tough path ahead of Alnylam's key ATTR-CM readout
Apr 22, 2024 10:55am
AZ's Alexion debuts short film highlighting NMOSD community
Apr 18, 2024 2:16pm
Amylyx to pull failed ALS drug from market, cut 70% of staff
Apr 4, 2024 10:06am
FDA expands AZ's Ultomiris to NMOSD after prior rejection
Mar 25, 2024 10:31am
Enspryng falls short of Roche's expectations in myasthenia gravis
Mar 21, 2024 11:28am